MK-212 (CHEM131475)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-04-14 18:36:37 UTC | ||||||||
| Update Date | 2026-05-14 19:17:24 UTC | ||||||||
| Accession Number | CHEM131475 | ||||||||
| Identification | |||||||||
| Common Name | MK-212 | ||||||||
| Class | Small Molecule | ||||||||
| Description | MK-212 is an organic compound with the formula C8H11ClN4 and an average molecular weight of 198.65 g/mol. MK-212 belongs to the piperazines, a subclass of diazinanes within the organic compounds. Classified as an organoheterocyclic compound, it acts as a modulator of the 5-hydroxytryptamine receptor 2C (HTR2C). | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C8H11ClN4 | ||||||||
| Average Molecular Mass | 198.650 g/mol | ||||||||
| Monoisotopic Mass | 198.067 g/mol | ||||||||
| CAS Registry Number | 64022-27-1 | ||||||||
| IUPAC Name | 2-chloro-6-(piperazin-1-yl)pyrazine | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | ClC1=NC(=CN=C1)N1CCNCC1 | ||||||||
| InChI Identifier | InChI=1S/C8H11ClN4/c9-7-5-11-6-8(12-7)13-3-1-10-2-4-13/h5-6,10H,1-4H2 | ||||||||
| InChI Key | CJAWPFJGFFNXQI-UHFFFAOYSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
